Thymosin Alpha-1

Thymosin Alpha-1

Level C
Thymosin Alpha-1

Editor: Dr. Jobby John, PharmD, FACA

Peptide Ledger review boards: Medical Review Board (Dr. Jobby John, PharmD, FACA; Dr. Richard Harris, MD, PharmD, MBA; Dr. Tracy Neal, MD; Dr. John Thoppil, MD; Dr. Natalie Kash, MD; Dr. Rahil Roopani, MD)Pharmacist Review Committee (Rachel Kuretich, PharmD, PharmD; Daniel Alonso, PharmD, PharmD; Christina Gunter, PharmD, PharmD; Patrick Gurley, PharmD, MS, PharmD, MS; Gyu-Hee Min, PharmD, PharmD)

References are being re-verified against PubMed and will return with review dates.

C
Emerging Evidence
Preclinical and animal studies with limited human data

Preclinical and animal studies with limited human data

Thymosin Alpha-1 is an immune-modulating peptide that is being studied for effects on T-cell function and immune system health. Originally isolated from the thymus gland, it plays a critical role in immune maturation and response. It is being studied for immune support, particularly in immunocompromised patients and chronic infections.

Thymosin Alpha-1 modulates the immune system through multiple pathways:

  • Has been reported to affect T-cell maturation and differentiation
  • Increases production of interleukin-2 and interferon-gamma
  • Activates natural killer (NK) cells
  • Has been reported to affect dendritic cell function
  • Modulates Toll-like receptor signaling
  • Has been reported to affect antibody responses
  • Reduces pro-inflammatory cytokines when excessive

These actions are being studied in relation to immune surveillance, viral clearance, and immune balance.

Generally well-tolerated with excellent safety profile:

  • Mild injection site reactions (redness, swelling)
  • Rare: transient fatigue or headache
  • Rare: mild allergic reactions

Serious adverse events are extremely rare. Decades of clinical use in other countries support safety.

Contraindicated in:

  • Hypersensitivity to Thymosin Alpha-1 or excipients
  • Autoimmune disorders (use with extreme caution under specialist supervision)
  • Pregnancy and lactation (insufficient data)

Precautions:

  • Monitor immune markers if possible
  • Use caution in organ transplant recipients
  • Assess autoimmune history before use
  • Medical supervision required

⚠️ Important safety information above

Dosing considerations for clinicians

Dosing considerations are available to verified clinicians.

Sign in for clinician access

Available through Lake Hills Pharmacy

Available through Lake Hills Pharmacy for verified clinicians. Contact us for more information.

Sign in as a verified clinician to see formulations and dosing.

Contact us for more information

For Healthcare Providers

New to Lake Hills Pharmacy? Join our provider network. Lake Hills Pharmacy is preparing peptide programs as regulatory guidance on compounded peptides develops. Contact us for more information.

Contact us for more information

For Patients

Interested in Thymosin Alpha-1? Connect with our medical team to discuss if this therapy is right for you.

or call us directly:

Clinical View: Complete drug monograph with evidence-based protocols. Switch to General View for patient-friendly information.

Important Information About Compounded Medications

These peptides are not FDA-approved but are commonly used by providers and patients under medical supervision. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. We provide evidence-based information from current research to help navigate this evolving field. Our goal is clear, evidence-based information for clinicians, with professional oversight at every step.

Lake Hills Pharmacy | Licensed 503A Compounding Pharmacy | Professional Medical Oversight Required